Small doses of aspirin can increase the chances of attacking cancer, according to a study by the American Institutes of Health (NIH) whose results were published in the Journal of the American Medical Association (JAMA).
US researchers have studied data on over 140,000 citizens collected for an average of 12.5 years, and found that among those who took aspirin one to three times a week, mortality was lower after developing cancers. prostate, colon and rectum, lung and ovary.
However, this trend has only been detected in people with normal weight. People whose weight was below or above the norm were not affected by this effect of aspirin.
The researchers also recognized that new studies were needed to determine the precise link between body mass index and the efficacy of aspirin as a potential way to prevent cancer.
In recent years, scientists have had a renewed interest in aspirin and other salicylic acid-based drugs that, as experiments have shown, have strong anti-cancer properties. Aspirin, according to doctors, is able to boost the effectiveness of immunotherapy, and fight against leukemia, colon cancer and several other tumors as well as increase the chances of survival after chemotherapy from 15 to 20%.
On the other hand, many institutions, including the US Food and Drug Administration (FDA), advise against or prohibit the use of aspirin because it can cause bleeding, stroke and worsening of ulcers because it dissolves thrombi in the cerebral and intestinal vessels.